Healthcare M&A Outlook Bright in 2018
Mar 14, 2018

IQVIA Consulting Principal Shriharsha Sarkar joins other experts in examining Asia's healthcare M&A outlook.

"While mega-mergers or acquisitions are becoming less common, big pharma is increasingly looking to snap up start-up biotech firms to inject growth in their pipelines," Shriharsha says.

You may also be interested in
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.